Sanofi Consumer Healthcare India Q4 Results 2025:Sanofi Consumer Healthcare India declared their Q4 results on 20 Feb, 2025. The topline decreased by 20.53% year-over-year (YoY), with profit falling by 34.66% YoY. The company’s profit stood at ₹44.3 crore and revenue at ₹170.7 crore.
Comparing Q4 to the previous quarter, revenue saw a slight increase of 6.75%, while profit experienced a decrease of 1.56%. The increase in revenue indicates some resilience despite the overall decline in annual performance.
The Selling, General & Administrative expenses rose by 0.73% quarter-over-quarter (q-o-q) and surged by 42.27% YoY, reflecting increased operational costs that have impacted profitability.
Operating income also faced challenges, down by 3.64% q-o-q and decreased by 33.03% YoY, showing the ongoing pressure on the company’s earnings capacity.
Earnings per share (EPS) for Q4 reported at ₹20.14, which is a significant drop of 32.93% YoY, underscoring the decline in profitability.
On a positive note, as of 21 Feb, 2025, out of 1 analyst covering the company, there has been a consensus recommendation of a Strong Buy, indicating potential confidence in future recovery.
The overall consensus recommendation as of 21 Feb, 2025 remains Strong Buy, suggesting optimism among analysts despite the current financial challenges faced by Sanofi Consumer Healthcare India.
Sanofi Consumer Healthcare India Financials
| Period | Q4 (FY24) | Q3 (FY24) | Q-o-Q Growth | Q4 (FY23) | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 170.7 | 159.9 | +6.75% | 214.8 | -20.53% |
| Selling/ General/ Admin Expenses Total | 27.6 | 27.4 | +0.73% | 19.4 | +42.27% |
| Depreciation/ Amortization | 1 | 1.5 | -33.33% | 0.9 | +11.11% |
| Total Operating Expense | 112.5 | 99.5 | +13.07% | 127.9 | -12.04% |
| Operating Income | 58.2 | 60.4 | -3.64% | 86.9 | -33.03% |
| Net Income Before Taxes | 62.8 | 61.2 | +2.61% | 89.5 | -29.83% |
| Net Income | 44.3 | 45 | -1.56% | 67.8 | -34.66% |
| Diluted Normalized EPS | 20.14 | 19.92 | +1.1% | 30.03 | -32.93% |
Disclaimer: This is an AI-generated live blog and has not been edited by LiveMint staff.
